Chromosomal aberrations in solid tumors

Progress in Molecular Biology and Translational Science

Volumn 95, Issue C, 2010, Pages 55-94

  Chinnaiyan, Arul M ^a,b,c,d   Palanisamy, Nallasivam ^a,b,d  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Comparative genomic hybridization; Fluorescent in situ hybridization; Gene fusion; MicroRNA; Sequencing; Solid tumor; Translocation

Indexed keywords

EID: 78649264107     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385071-3.00004-6     Document Type: Chapter

References (166)

1. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
2. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
3. H. Rajagopalan, and C. Lengauer Aneuploidy and cancer Nature 432 2004 338 341
4. T. Sugimura, M. Terada, J. Yokota, S. Hirohashi, and K. Wakabayashi Multiple genetic alterations in human carcinogenesis Environ Health Perspect 98 1992 5 12
5. T. Ried, K. Heselmeyer-Haddad, H. Blegen, E. Schrock, and G. Auer Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation Genes Chromosom Cancer 25 1999 195 204
6. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
7. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
8. J. Cheng, P. Kapranov, J. Drenkow, S. Dike, S. Brubaker, and S. Patel Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution Science 308 2005 1149 1154
9. E. Birney, J.A. Stamatoyannopoulos, A. Dutta, R. Guigo, T.R. Gingeras, and E.H. Margulies Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project Nature 447 2007 799 816
10. S. Washietl, J.S. Pedersen, J.O. Korbel, C. Stocsits, A.R. Gruber, and J. Hackermuller Structured RNAs in the ENCODE selected regions of the human genome Genome Res 17 2007 852 864
11. L. Poliseno, L. Salmena, J. Zhang, B. Carver, W.J. Haveman, and P.P. Pandolfi A coding-independent function of gene and pseudogene mRNAs regulates tumour biology Nature 465 2010 1033 1038
12. S.A. Tomlins, D.R. Rhodes, S. Perner, S.M. Dhanasekaran, R. Mehra, and X.W. Sun Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648
13. H. Mano Novel EML4-ALK fusion oncogene in lung cancer Rinsho Ketsueki 50 2009 468 473
14. T. Boveri Anton Dohbn Science 36 1912 453 468
15. J.H. Tjio, and A. Levan The chromosome number of man Hereditas 42 1956 1 6
16. P.C. Nowell, and D.A. Hungerford A minute chromosome in human chronic granulocytic leukemia Science 132 1960 1497 1501
17. P.C. Nowell, and D.A. Hungerford Chromosome studies on normal and leukemic human leukocytes J Natl Cancer Inst 25 1960 85 109
18. T. Caspersson, G. Lomakka, and L. Zech The 24 fluorescence patterns of human metaphase chromosomes- distinguishing characters and variability Hereditas 67 1 1972 89 102
19. J.D. Rowley Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining Nature 243 1973 290 293
20. R. Ren Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia Nat Rev Cancer 5 2005 172 183
21. S. Li, R.L. Ilaria Jr., R.P. Million, G.Q. Daley, and R.A. Van Etten The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity J Exp Med 189 1999 1399 1412
22. P.A. Futreal, L. Coin, M. Marshall, T. Down, T. Hubbard, and R. Wooster A census of human cancer genes Nat Rev Cancer 4 2004 177 183
23. F. Mitelman, B. Johansson, and F. Mertens Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer Nat Genet 36 2004 331 334
24. F. Mitelman, F. Mertens, and B. Johansson Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders Genes Chromosom Cancer 43 2005 350 366
25. B.J. Druker, and N.B. Lydon Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia J Clin Invest 105 2000 3 7
26. J. Tsai, J.T. Lee, W. Wang, J. Zhang, H. Cho, and S. Mamo Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity Proc Natl Acad Sci USA 105 2008 3041 3046
27. J.N. McAlpine, K.C. Wiegand, R. Vang, B.M. Ronnett, A. Adamiak, and M. Kobel HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy BMC Cancer 9 2009 433
28. F.J. Novo, I.O. de Mendibil, and J.L. Vizmanos TICdb: a collection of gene-mapped translocation breakpoints in cancer BMC Genomics 8 2007 33
29. F. Mitelman, B. Johansson, and F. Mertens The impact of translocations and gene fusions on cancer causation Nat Rev Cancer 7 2007 233 245
30. O. Delattre, J. Zucman, B. Plougastel, C. Desmaze, T. Melot, and M. Peter Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours Nature 359 1992 162 165
31. C. Desmaze, F. Brizard, C. Turc-Carel, T. Melot, O. Delattre, and G. Thomas Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors Cancer Genet Cytogenet 97 1997 12 19
32. S. Ishida, K. Yoshida, Y. Kaneko, Y. Tanaka, Y. Sasaki, and F. Urano The genomic breakpoint and chimeric transcripts in the EWSR1-ETV4/E1AF gene fusion in Ewing sarcoma Cytogenet Cell Genet 82 1998 278 283
33. M. Peter, J. Couturier, H. Pacquement, J. Michon, G. Thomas, and H. Magdelenat A new member of the ETS family fused to EWS in Ewing tumors Oncogene 14 1997 1159 1164
34. D.C. Shing, D.J. McMullan, P. Roberts, K. Smith, S.F. Chin, and J. Nicholson FUS/ERG gene fusions in Ewing's tumors Cancer Res 63 2003 4568 4576
35. I.S. Jeon, J.N. Davis, B.S. Braun, J.E. Sublett, M.F. Roussel, and C.T. Denny A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1 Oncogene 10 1995 1229 1234
36. M. Kawamura-Saito, Y. Yamazaki, K. Kaneko, N. Kawaguchi, H. Kanda, and H. Mukai Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation Hum Mol Genet 15 2006 2125 2137
37. T. Mastrangelo, P. Modena, S. Tornielli, F. Bullrich, M.A. Testi, and A. Mezzelani A novel zinc finger gene is fused to EWS in small round cell tumor Oncogene 19 2000 3799 3804
38. J. Kim, K. Lee, and J. Pelletier The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct Oncogene 16 1998 1021 1030
39. B. Lawrence, A. Perez-Atayde, M.K. Hibbard, B.P. Rubin, P. Dal Cin, and J.L. Pinkus TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors Am J Pathol 157 2000 377 384
40. I. Panagopoulos, T. Nilsson, H.A. Domanski, M. Isaksson, P. Lindblom, and F. Mertens Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor Int J Cancer 118 2006 1181 1186
41. G.W. Colleoni, J.A. Bridge, B. Garicochea, J. Liu, D.A. Filippa, and M. Ladanyi ATIC-ALK: a novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35) Am J Pathol 156 2000 781 789
42. Z. Ma, D.A. Hill, M.H. Collins, S.W. Morris, J. Sumegi, and M. Zhou Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor Genes Chromosom Cancer 37 2003 98 105
43. J.A. Bridge, M. Kanamori, Z. Ma, D. Pickering, D.A. Hill, and W. Lydiatt Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor Am J Pathol 159 2001 411 415
44. L.V. Debelenko, D.C. Arthur, S.D. Pack, L.J. Helman, D.S. Schrump, and M. Tsokos Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor Lab Invest 83 2003 1255 1265
45. C.E. Comin, L. Novelli, D. Tornaboni, and L. Messerini Clear cell sarcoma of the ileum: report of a case and review of literature Virchows Arch 451 2007 839 845
46. C. Filion, and Y. Labelle The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells Exp Cell Res 297 2004 585 592
47. I. Panagopoulos, M. Mencinger, C.U. Dietrich, B. Bjerkehagen, G. Saeter, and F. Mertens Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11) Oncogene 18 1999 7594 7598
48. H. Sjogren, B. Wedell, J.M. Meis-Kindblom, L.G. Kindblom, and G. Stenman Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21) Cancer Res 60 2000 6832 6835
49. M. Hisaoka, T. Ishida, T. Imamura, and H. Hashimoto TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma Genes Chromosom Cancer 40 2004 325 328
50. P.H. Sorensen, J.C. Lynch, S.J. Qualman, R. Tirabosco, J.F. Lim, and H.M. Maurer PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group J Clin Oncol 20 2002 2672 2679
51. M. Wachtel, M. Dettling, E. Koscielniak, S. Stegmaier, J. Treuner, and K. Simon-Klingenstein Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1 Cancer Res 64 2004 5539 5545
52. M.H. Collins, H. Zhao, R.B. Womer, and F.G. Barr Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions Med Pediatr Oncol 37 2001 83 89
53. B. de Leeuw, M. Balemans, D. Olde Weghuis, and A. Geurts van Kessel Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas Hum Mol Genet 4 1995 1097 1099
54. B. Skytting, G. Nilsson, B. Brodin, Y. Xie, J. Lundeberg, and M. Uhlen A novel fusion gene, SYT-SSX4, in synovial sarcoma J Natl Cancer Inst 91 1999 974 975
55. H. Kanoe, T. Nakayama, T. Hosaka, H. Murakami, H. Yamamoto, and Y. Nakashima Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation Oncogene 18 1999 721 729
56. R. Alaggio, C.M. Coffin, S.W. Weiss, J.A. Bridge, J. Issakov, and A.M. Oliveira Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age Am J Surg Pathol 33 2009 645 658
57. J. Wang, Y. Morimitsu, S. Okamoto, M. Hisaoka, T. Ishida, and W. Sheng COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans J Mol Diagn 2 2000 47 52
58. S.R. Knezevich, D.E. McFadden, W. Tao, J.F. Lim, and P.H. Sorensen A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma Nat Genet 18 1998 184 187
59. B.L. Waters, I. Panagopoulos, and E.F. Allen Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11 Cancer Genet Cytogenet 121 2000 109 116
60. P. Argani, C.R. Antonescu, P.B. Illei, M.Y. Lui, C.F. Timmons, and R. Newbury Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents Am J Pathol 159 2001 179 192
61. M.J. Hernandez-Marti, C. Orellana-Alonso, L. Badia-Garrabou, A. Verdeguer Miralles, and A. Paradis-Alos Renal adenocarcinoma in an 8-year-old child, with a t(X;17)(p11.2;q25) Cancer Genet Cytogenet 83 1995 82 83
62. A. Matsuyama, M. Hisaoka, S. Shimajiri, and H. Hashimoto DNA-based polymerase chain reaction for detecting FUS-CREB3L2 in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens Diagn Mol Pathol 17 2008 237 240
63. F. Mertens, C.D. Fletcher, C.R. Antonescu, J.M. Coindre, M. Colecchia, and H.A. Domanski Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene Lab Invest 85 2005 408 415
64. I. Panagopoulos, F. Mertens, and C.A. Griffin An endometrial stromal sarcoma cell line with the JAZF1/PHF1 chimera Cancer Genet Cytogenet 185 2008 74 77
65. F. Micci, I. Panagopoulos, B. Bjerkehagen, and S. Heim Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma Cancer Res 66 2006 107 112
66. S. Yamaguchi, Y. Yamazaki, Y. Ishikawa, N. Kawaguchi, H. Mukai, and T. Nakamura EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12) Genes Chromosom Cancer 43 2005 217 222
67. M.G. Butti, I. Bongarzone, G. Ferraresi, P. Mondellini, M.G. Borrello, and M.A. Pierotti A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas Genomics 28 1995 15 24
68. A. Greco, C. Miranda, S. Pagliardini, L. Fusetti, I. Bongarzone, and M.A. Pierotti Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes Genes Chromosom Cancer 19 1997 112 123
69. R. Giannini, G. Salvatore, C. Monaco, F. Sferratore, L. Pollina, and F. Pacini Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis Int J Oncol 16 2000 485 489
70. R. Elisei, C. Romei, M.G. Castagna, S. Lisi, A. Vivaldi, and P. Faviana RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration Thyroid 15 2005 1355 1361
71. S. Klugbauer, and H.M. Rabes The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas Oncogene 18 1999 4388 4393
72. T. Nakata, Y. Kitamura, K. Shimizu, S. Tanaka, M. Fujimori, and S. Yokoyama Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma Genes Chromosom Cancer 25 1999 97 103
73. K. Salassidis, J. Bruch, H. Zitzelsberger, E. Lengfelder, A.M. Kellerer, and M. Bauchinger Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma Cancer Res 60 2000 2786 2789
74. S. Klugbauer, E.P. Demidchik, E. Lengfelder, and H.M. Rabes Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5 Cancer Res 58 1998 198 203
75. R. Corvi, N. Berger, R. Balczon, and G. Romeo RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma Oncogene 19 2000 4236 4242
76. V. Saenko, T. Rogounovitch, Y. Shimizu-Yoshida, A. Abrosimov, E. Lushnikov, and P. Roumiantsev Novel tumorigenic rearrangement, Delta rfp/ret, in a papillary thyroid carcinoma from externally irradiated patient Mutat Res 527 2003 81 90
77. R. Ciampi, T.J. Giordano, K. Wikenheiser-Brokamp, R.J. Koenig, and Y.E. Nikiforov HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma Endocr Relat Cancer 14 2007 445 452
78. T.G. Kroll, P. Sarraf, L. Pecciarini, C.J. Chen, E. Mueller, and B.M. Spiegelman PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected] Science 289 2000 1357 1360
79. R. Ciampi, J.A. Knauf, R. Kerler, M. Gandhi, Z. Zhu, and M.N. Nikiforova Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer J Clin Invest 115 2005 94 101
80. T. Forshew, R.G. Tatevossian, A.R. Lawson, J. Ma, G. Neale, and B.W. Ogunkolade Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas J Pathol 218 2009 172 181
81. B. Dessars, L.E. De Raeve, H. El Housni, C.J. Debouck, P.J. Sidon, and R. Morandini Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi J Invest Dermatol 127 2007 1468 1470
82. N. Palanisamy, B. Ateeq, S. Kalyana-Sundaram, D. Pflueger, K. Ramnarayanan, and S. Shankar Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma Nat Med 16 7 2010 793 798
83. C.A. Maher, N. Palanisamy, J.C. Brenner, X. Cao, S. Kalyana-Sundaram, and S. Luo Chimeric transcript discovery by paired-end transcriptome sequencing Proc Natl Acad Sci USA 106 2009 12353 12358
84. R. Esgueva, S. Perner, C. J LaFargue, V. Scheble, C. Stephan, and M. Lein Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort Mod Pathol 23 4 2010 539 546
85. D. Pflueger, D.S. Rickman, A. Sboner, S. Perner, C.J. LaFargue, and M.A. Svensson N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer Neoplasia 11 2009 804 811
86. K.G. Hermans, H.A. van der Korput, R. van Marion, D.J. van de Wijngaart, A. Ziel-van der Made, and N.F. Dits Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer Cancer Res 68 2008 7541 7549
87. D.S. Rickman, D. Pflueger, B. Moss, V.E. VanDoren, C.X. Chen, and A. de la Taille SLC45A3-ELK4 is a novel and frequent erythroblast transformation- specific fusion transcript in prostate cancer Cancer Res 69 2009 2734 2738
88. S.A. Tomlins, B. Laxman, S.M. Dhanasekaran, B.E. Helgeson, X. Cao, and D.S. Morris Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer Nature 448 2007 595 599
89. G. Attard, J. Clark, L. Ambroisine, I.G. Mills, G. Fisher, and P. Flohr Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer Br J Cancer 99 2008 314 320
90. B. Han, R. Mehra, S.M. Dhanasekaran, J. Yu, A. Menon, and R.J. Lonigro A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer Cancer Res 68 2008 7629 7637
91. S.A. Tomlins, R. Mehra, D.R. Rhodes, L.R. Smith, D. Roulston, and B.E. Helgeson TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer Cancer Res 66 2006 3396 3400
92. K.G. Hermans, A.A. Bressers, H.A. van der Korput, N.F. Dits, G. Jenster, and J. Trapman Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer Cancer Res 68 2008 3094 3098
93. B.E. Helgeson, S.A. Tomlins, N. Shah, B. Laxman, Q. Cao, and J.R. Prensner Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer Cancer Res 68 2008 73 80
94. K. Shinmura, S. Kageyama, H. Tao, T. Bunai, M. Suzuki, and T. Kamo EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas Lung Cancer 61 2008 163 169
95. K.H. Hallor, F. Mertens, Y. Jin, J.M. Meis-Kindblom, L.G. Kindblom, and M. Behrendtz Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma Genes Chromosom Cancer 44 2005 97 102
96. A. Buijs, L. van Rompaey, A.C. Molijn, J.N. Davis, A.C. Vertegaal, and M.D. Potter The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity Mol Cell Biol 20 2000 9281 9293
97. A. Charest, K. Lane, K. McMahon, J. Park, E. Preisinger, and H. Conroy Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21) Genes Chromosom Cancer 37 2003 58 71
98. C. Tognon, S.R. Knezevich, D. Huntsman, C.D. Roskelley, N. Melnyk, and J.A. Mathers Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma Cancer Cell 2 2002 367 376
99. A. Skalova, T. Vanecek, R. Sima, J. Laco, I. Weinreb, and B. Perez-Ordonez Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity Am J Surg Pathol 34 2010 599 608
100. J. Anderson, S. Gibson, and N.J. Sebire Expression of ETV6-NTRK in classical, cellular and mixed subtypes of congenital mesoblastic nephroma Histopathology 48 2006 748 753
101. V. Rajaram, S. Knezevich, K.E. Bove, A. Perry, and J.D. Pfeifer DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t(11;19)(q11;q13.4) translocation Genes Chromosom Cancer 46 2007 508 513
102. S.K. Sidhar, J. Clark, S. Gill, R. Hamoudi, A.J. Crew, and R. Gwilliam The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene Hum Mol Genet 5 1996 1333 1338
103. S. Aulmann, T. Longerich, P. Schirmacher, G. Mechtersheimer, and R. Penzel Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas Histopathology 50 2007 881 886
104. R.P. Kuiper, M. Schepens, J. Thijssen, M. van Asseldonk, E. van den Berg, and J. Bridge Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution Hum Mol Genet 12 2003 1661 1669
105. I.J. Davis, B.L. Hsi, J.D. Arroyo, S.O. Vargas, Y.A. Yeh, and G. Motyckova Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation Proc Natl Acad Sci USA 100 2003 6051 6056
106. M. Tanaka, K. Kato, K. Gomi, M. Matsumoto, H. Kudo, and M. Shinkai Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma Am J Surg Pathol 33 2009 1416 1420
107. N. Kuroda, M. Tamura, Y. Tanaka, O. Hes, M. Michal, and K. Inoue Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels Pathol Int 59 2009 486 491
108. P. Argani, M.Y. Lui, J. Couturier, R. Bouvier, J.C. Fournet, and M. Ladanyi A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23) Oncogene 22 2003 5374 5378
109. P. Heimann, H. El Housni, G. Ogur, M.A. Weterman, E.M. Petty, and G. Vassart Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)- bearing papillary renal cell carcinomas Cancer Res 61 2001 4130 4135
110. J. Adelaide, M. Chaffanet, M.J. Mozziconacci, C. Popovici, N. Conte, and F. Fernandez Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line Int J Oncol 16 2000 683 688
111. X.Z. Wang, E.M. Jolicoeur, N. Conte, M. Chaffanet, Y. Zhang, and M.J. Mozziconacci gamma-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line Oncogene 18 1999 5718 5721
112. Y. Hahn, T.K. Bera, K. Gehlhaus, I.R. Kirsch, I.H. Pastan, and B. Lee Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases Proc Natl Acad Sci USA 101 2004 13257 13261
113. C.A. French, C.L. Ramirez, J. Kolmakova, T.T. Hickman, M.J. Cameron, and M.E. Thyne BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells Oncogene 27 2008 2237 2242
114. K. Kas, M.L. Voz, E. Roijer, A.K. Astrom, E. Meyen, and G. Stenman Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations Nat Genet 15 1997 170 174
115. M.L. Voz, A.K. Astrom, K. Kas, J. Mark, G. Stenman, and W.J. Van de Ven The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter Oncogene 16 1998 1409 1416
116. J. Asp, F. Persson, M. Kost-Alimova, and G. Stenman CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas Genes Chromosom Cancer 45 2006 820 828
117. J.M. Geurts, E.F. Schoenmakers, E. Roijer, G. Stenman, and W.J. Van de Ven Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland Cancer Res 57 1997 13 17
118. M. Nilsson, I. Panagopoulos, F. Mertens, and N. Mandahl Fusion of the HMGA2 and NFIB genes in lipoma Virchows Arch 447 2005 855 858
119. A. Pierron, C. Fernandez, E. Saada, F. Keslair, G. Hery, and H. Zattara HMGA2-NFIB fusion in a pediatric intramuscular lipoma: a novel case of NFIB alteration in a large deep-seated adipocytic tumor Cancer Genet Cytogenet 195 2009 66 70
120. M. Winnes, L. Molne, M. Suurkula, Y. Andren, F. Persson, and F. Enlund Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas Genes Chromosom Cancer 46 2007 559 563
121. T. Nakayama, S. Miyabe, M. Okabe, H. Sakuma, K. Ijichi, and Y. Hasegawa Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma Mod Pathol 22 2009 1575 1581
122. M.A. Pearson, and D. Fabbro Targeting protein kinases in cancer therapy: a success? Expert Rev Anticancer Ther 4 2004 1113 1124
123. S.K. Grant Therapeutic protein kinase inhibitors Cell Mol Life Sci 66 2009 1163 1177
124. P. Brennan, R. Donev, and S. Hewamana Targeting transcription factors for therapeutic benefit Mol Biosyst 4 2008 909 919
125. D.A. Frank Targeting transcription factors for cancer therapy IDrugs 12 2009 29 33
126. H.C. Hurst Transcription factors as drug targets in cancer Eur J Cancer 32A 1996 1857 1863
127. M. Soda, Y.L. Choi, M. Enomoto, S. Takada, Y. Yamashita, and S. Ishikawa Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 2007 561 566
128. J.W. MacDonald, and D. Ghosh COPAcancer outlier profile analysis Bioinformatics 22 2006 2950 2951
129. D.F. Claxton, P. Liu, H.B. Hsu, P. Marlton, J. Hester, and F. Collins Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia Blood 83 1994 1750 1756
130. R. Mehra, S.A. Tomlins, J. Yu, X. Cao, L. Wang, and A. Menon Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer Cancer Res 68 2008 3584 3590
131. P.B. Sinclair, E.P. Nacheva, M. Leversha, N. Telford, J. Chang, and A. Reid Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia Blood 95 2000 738 743
132. S. Varambally, Q. Cao, R.S. Mani, S. Shankar, X. Wang, and B. Ateeq Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer Science 322 2008 1695 1699
133. M.M. Tanner, M. Tirkkonen, A. Kallioniemi, K. Holli, C. Collins, and D. Kowbel Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications Clin Cancer Res 1 1995 1455 1461
134. P.M. Haverty, J. Fridlyand, L. Li, G. Getz, R. Beroukhim, and S. Lohr High-resolution genomic and expression analyses of copy number alterations in breast tumors Genes Chromosom Cancer 47 2008 530 542
135. Z. Kan, B.S. Jaiswal, J. Stinson, V. Janakiraman, D. Bhatt, and H.M. Stern Diverse somatic mutation patterns and pathway alterations in human cancers Nature 2010 10.1038/nature09208
136. C.A. Maher, C. Kumar-Sinha, X. Cao, S. Kalyana-Sundaram, B. Han, and X. Jing Transcriptome sequencing to detect gene fusions in cancer Nature 458 2009 97 101
137. A.A. Sandberg, C. Turc-Carel, and R.M. Gemmill Chromosomes in solid tumors and beyond Cancer Res 48 1988 1049 1059
138. N. Mandahl, S. Heim, K. Arheden, A. Rydholm, H. Willen, and F. Mitelman Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas Hum Genet 79 1988 203 208
139. J. Mark, G. Havel, C. Grepp, R. Dahlenfors, and B. Wedell Cytogenetical observations in human benign uterine leiomyomas Anticancer Res 8 1988 621 626
140. N.B. Atkin Lack of reciprocal translocations in carcinomas Cancer Genet Cytogenet 21 1986 275 278
141. E. Schrock, S. du Manoir, T. Veldman, B. Schoell, J. Wienberg, and M.A. Ferguson-Smith Multicolor spectral karyotyping of human chromosomes Science 273 1996 494 497
142. S. Iida, P.H. Rao, P. Nallasivam, H. Hibshoosh, M. Butler, and D.C. Louie The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene Blood 88 1996 4110 4117
143. V.G. Dyomin, N. Palanisamy, K.O. Lloyd, K. Dyomina, S.C. Jhanwar, and J. Houldsworth MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets Blood 95 2000 2666 2671
144. W. Chen, N. Palanisamy, H. Schmidt, J. Teruya-Feldstein, S.C. Jhanwar, and A.D. Zelenetz Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas Oncogene 20 2001 7686 7693
145. G. Hatzivassiliou, I. Miller, J. Takizawa, N. Palanisamy, P.H. Rao, and S. Iida IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy Immunity 14 2001 277 289
146. G.W. Dewald, W.A. Wyatt, A.L. Juneau, R.O. Carlson, A.R. Zinsmeister, and S.M. Jalal Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia Blood 91 1998 3357 3365
147. M.T. Barrett, A. Scheffer, A. Ben-Dor, N. Sampas, D. Lipson, and R. Kincaid Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA Proc Natl Acad Sci USA 101 2004 17765 17770
148. N. Kawamata, S. Ogawa, M. Zimmermann, B. Niebuhr, C. Stocking, and M. Sanada Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray Proc Natl Acad Sci USA 105 2008 11921 11926
149. N. Lisitsyn, and M. Wigler Cloning the differences between two complex genomes Science 259 1993 946 951
150. I. Hatada, Y. Hayashizaki, S. Hirotsune, H. Komatsubara, and T. Mukai A genomic scanning method for higher organisms using restriction sites as landmarks Proc Natl Acad Sci USA 88 1991 9523 9527
151. S. Hirotsune, I. Hatada, H. Komatsubara, H. Nagai, K. Kuma, and K. Kobayakawa New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning Cancer Res 52 1992 3642 3647
152. P. Ng, C.L. Wei, W.K. Sung, K.P. Chiu, L. Lipovich, and C.C. Ang Gene identification signature (GIS) analysis for transcriptome characterization and genome annotation Nat Meth 2 2005 105 111
153. S. Volik, S. Zhao, K. Chin, J.H. Brebner, D.R. Herndon, and Q. Tao End-sequence profiling: sequence-based analysis of aberrant genomes Proc Natl Acad Sci USA 100 2003 7696 7701
154. T.L. Wang, C. Maierhofer, M.R. Speicher, C. Lengauer, B. Vogelstein, and K.W. Kinzler Digital karyotyping Proc Natl Acad Sci USA 99 2002 16156 16161
155. V. Jobanputra, J. Sebat, J. Troge, W. Chung, K. Anyane-Yeboa, and M. Wigler Application of ROMA (representational oligonucleotide microarray analysis) to patients with cytogenetic rearrangements Genet Med 7 2005 111 118
156. M.A. Quail, I. Kozarewa, F. Smith, A. Scally, P.J. Stephens, and R. Durbin A large genome center's improvements to the Illumina sequencing system Nat Meth 5 2008 1005 1010
157. R. Jothi, S. Cuddapah, A. Barski, K. Cui, and K. Zhao Genome-wide identification of in vivo protein-DNA binding sites from ChIP-Seq data Nucleic Acids Res 36 2008 5221 5231
158. S.J. Emrich, W.B. Barbazuk, L. Li, and P.S. Schnable Gene discovery and annotation using LCM-454 transcriptome sequencing Genome Res 17 2007 69 73
159. V.E. Velculescu, L. Zhang, B. Vogelstein, and K.W. Kinzler Serial analysis of gene expression Science 270 1995 484 487
160. R. Kodzius, M. Kojima, H. Nishiyori, M. Nakamura, S. Fukuda, and M. Tagami CAGE: cap analysis of gene expression Nat Meth 3 2006 211 222
161. S. Brenner, M. Johnson, J. Bridgham, G. Golda, D.H. Lloyd, and D. Johnson Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays Nat Biotechnol 18 2000 630 634
162. E.S. Lander, L.M. Linton, B. Birren, C. Nusbaum, M.C. Zody, and J. Baldwin Initial sequencing and analysis of the human genome Nature 409 2001 860 921
163. H. Davies, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, and S. Clegg Mutations of the BRAF gene in human cancer Nature 417 2002 949 954
164. R.S. Mani, S.A. Tomlins, K. Callahan, A. Ghosh, M.K. Nyati, and S. Varambally Induced chromosomal proximity and gene fusions in prostate cancer Science 326 2009 1230
165. C. Lin, L. Yang, B. Tanasa, K. Hutt, B.G. Ju, and K. Ohgi Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer Cell 139 2009 1069 1083
166. E.C. Collins, and T.H. Rabbitts The promiscuous MLL gene links